ELIXIR.LU news


ELIXIR facilitates development of COVID-19 Disease Map
ELIXIR Nodes contribute to the development of a knowledgebase of SARS-CoV-2 virus host-pathogen interactions. Announced last week in Scientific data, the COVID-19 Disease Map is an international effort to organise the molecular processes underlying the virus-host interactions in COVID-19. Based on the rapidly growing body of scientific literature and curated by domain...
ELIXIR-CONVERGE — a new project to streamline data management practices
After the completion of the successful ELIXIR-EXCELERATE project, which provided ELIXIR with solid foundations, ELIXIR kicks off a new project to support the provision of data management across Europe. ELIXIR-CONVERGE, a €5 million three-year H2020 project, will bring together experts from all 23 ELIXIR Nodes, representing 29 research institutes and 22 countries...
Joint meeting hosted in Belval
On November 25 to 27, ELIXIR Luxembourg hosted the ELIXIR Compute Platform Face-to-Face meeting and the EOSC-Life Work Package 5/7 joint meeting on the Belval campus of the University of Luxembourg. During the meeting, around 30 participants gave updates on each task in the platform and discussed the extension and linking to...
National stakeholders meeting 2019 for ELIXIR-LU
In September 2019, The ELIXIR-LU team organised its Annual National Stakeholder Forum to give updates on the ELIXIR infrastructure on the European as well as the national level and discuss strategic future developments. More than twenty participants attended the meeting, representing over 15 institutions in Luxembourg ranging from ministries and biomedical research...
Smart4Health project leaders meet at Belval
On May 15-16, Smart4Health leaders met to exchange on the latest progress and work plans in this ambitious new international EU project. As one of three Luxembourg partners, ELIXIR-LU hosted the event and discussed its plans for realising ‘data donations’ from citizens to researchers in Europe with help of the research infrastructure...
IMI2: FAIRPlus grant awarded
ELIXIR-LU is a partner in the FAIRplus consortium, coordinated by the ELIXIR Hub, which will support EFPIA companies (European Federation of Pharmaceutical Industries and Associations) and specific IMI projects in making their data FAIR: Findable, Accessible, Interoperable and Reusable. The proposal was submitted to the Innovative Medicines Initiative (IMI2) in response to...
Luxinnovation celebrates the 10 years of IMI
On the occasion of the tenth anniversary of the Innovative Medicines Initiative (IMI), Luxinnovation interviewed Prof Dr Reinhard Schneider, Head of ELIXIR-LU. The interview focused on the involvement of ELIXIR-LU and of the Bioinformatics Core of the Luxembourg Centre for Systems Biomedicine (LCSB) in IMI projects. It highlights the expertise of the...